HomeReleasesMindMaze to Bring Neurorehabilitation Home via Tab...
Releases

MindMaze to Bring Neurorehabilitation Home via Tablet-Based Platform

MindMaze to Bring Neurorehabilitation Home via Tablet-Based Platform

By the end of 2026, patients recovering from stroke and neurological conditions will gain access to intensive, home-based neurorehabilitation through a new tablet-based solution. MindMaze Therapeutics plans to deploy MindMotion Lite, a streamlined version of its existing therapy platform, to bridge the critical gap between clinical care and home recovery.

MindMotion Lite distills the full spectrum of neurotherapeutic activities found in the company’s MindMotion GO system into a portable, tablet-based format. This shift significantly lowers hardware barriers for home deployment while maintaining the full-body movement capabilities essential for intensive training. The device also integrates teleconsultation tools, allowing healthcare providers to monitor patient progress and adjust treatment plans remotely.

CEO Zach Henderson noted that the move addresses a persistent shortage in rehabilitation intensity, a standard recently highlighted in the August 2026 updates to AHA/ASA guidelines. By aligning with existing reimbursement codes, the platform aims to make consistent recovery routines more financially viable for providers and accessible for patients. The company intends to showcase the technology at upcoming industry conferences as it prepares for a broader commercial rollout, positioning the tablet as a scalable, capital-efficient alternative to its current specialized hardware configurations.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!